Evidence map›Paper›PMID 25712351›Full record

ArticleAntimicrobial agents and chemotherapy2015

Persistence and epidemic propagation of a Pseudomonas aeruginosa sequence type 235 clone harboring an IS26 composite transposon carrying the blaIMP-1 integron in Hiroshima, Japan, 2005 to 2012.

Wataru Shimizu, Shizuo Kayama, Shuntaro Kouda, Yoshitoshi Ogura, Kanao Kobayashi, Norifumi Shigemoto, Norimitsu Shimada, Raita Yano, Junzo Hisatsune, Fuminori Kato and 4 more

Open access · bronzeAbstract read
In one paragraph

Article in Antimicrobial agents and chemotherapy, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
0.5field-weighted citation impact, top 41% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 15 citations in OpenAlex.

  1. Nationwide genome surveillance of carbapenem-resistantAntimicrobial agents and chemotherapy · 2024
    Article
  2. Article
  3. Antibiotic Resistance in Pseudomonas.Advances in experimental medicine and biology · 2022
    Article
  4. Article
  5. Article
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors at 5 institutions in 1 country.

Wataru ShimizuProject Research Center for Nosocomial Infectious Diseases, Hiroshima University, Hiroshima, Japan Department of Bacteriology, Graduate School of Biomedical and Health Sciences, Hiroshima University, Hiroshima, Japan Department of Surgery, Hiroshima University, Hiroshima, Japan.
Shizuo KayamaProject Research Center for Nosocomial Infectious Diseases, Hiroshima University, Hiroshima, Japan Department of Bacteriology, Graduate School of Biomedical and Health Sciences, Hiroshima University, Hiroshima, Japan.
Shuntaro KoudaProject Research Center for Nosocomial Infectious Diseases, Hiroshima University, Hiroshima, Japan Department of Bacteriology, Graduate School of Biomedical and Health Sciences, Hiroshima University, Hiroshima, Japan Department of Urology, National Hospital Organization Kure Medical Center, Kure City, Hiroshima, Japan.
Yoshitoshi OguraDivision of Microbial Genomics, Department of Genomics and Bioenvironmental Science, Frontier Science Research Center, University of Miyazaki, Miyazaki, Japan Division of Microbiology, Department of Infectious Diseases, Faculty of Medicine, University of Miyazaki, Miyazaki, Japan.
Kanao KobayashiProject Research Center for Nosocomial Infectious Diseases, Hiroshima University, Hiroshima, Japan Department of Bacteriology, Graduate School of Biomedical and Health Sciences, Hiroshima University, Hiroshima, Japan Department of Urology, Chugoku Rousai Hospital, Kure, Hiroshima, Japan.
Norifumi ShigemotoProject Research Center for Nosocomial Infectious Diseases, Hiroshima University, Hiroshima, Japan Department of Infectious Diseases, Hiroshima University Hospital, Hiroshima, Japan.
Norimitsu ShimadaProject Research Center for Nosocomial Infectious Diseases, Hiroshima University, Hiroshima, Japan Department of Bacteriology, Graduate School of Biomedical and Health Sciences, Hiroshima University, Hiroshima, Japan Department of Surgery, Hiroshima University, Hiroshima, Japan.
Raita YanoProject Research Center for Nosocomial Infectious Diseases, Hiroshima University, Hiroshima, Japan Department of Bacteriology, Graduate School of Biomedical and Health Sciences, Hiroshima University, Hiroshima, Japan Department of Surgery, Hiroshima University, Hiroshima, Japan.
Junzo HisatsuneProject Research Center for Nosocomial Infectious Diseases, Hiroshima University, Hiroshima, Japan Department of Bacteriology, Graduate School of Biomedical and Health Sciences, Hiroshima University, Hiroshima, Japan.
Fuminori KatoProject Research Center for Nosocomial Infectious Diseases, Hiroshima University, Hiroshima, Japan Department of Bacteriology, Graduate School of Biomedical and Health Sciences, Hiroshima University, Hiroshima, Japan.
Tetsuya HayashiDivision of Microbial Genomics, Department of Genomics and Bioenvironmental Science, Frontier Science Research Center, University of Miyazaki, Miyazaki, Japan Division of Microbiology, Department of Infectious Diseases, Faculty of Medicine, University of Miyazaki, Miyazaki, Japan.
Taijiro SuedaDepartment of Surgery, Hiroshima University, Hiroshima, Japan.
Hiroki OhgeProject Research Center for Nosocomial Infectious Diseases, Hiroshima University, Hiroshima, Japan Department of Infectious Diseases, Hiroshima University Hospital, Hiroshima, Japan.
Motoyuki SugaiProject Research Center for Nosocomial Infectious Diseases, Hiroshima University, Hiroshima, Japan Department of Bacteriology, Graduate School of Biomedical and Health Sciences, Hiroshima University, Hiroshima, Japan sugai@hiroshima-u.ac.jp.
Hiroshima University · JPHiroshima University Hospital · JPUniversity of Miyazaki · JPChugoku Rosai Hospital · JPKure Medical Center · JP

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

A 9-year surveillance for multidrug-resistant (MDR) Pseudomonas aeruginosa in the Hiroshima region showed that the number of isolates harboring the metallo-β-lactamase gene bla(IMP-1) abruptly increased after 2004, recorded the highest peak in 2006, and showed a tendency to decline afterwards, indicating a history of an epidemic. PCR mapping of the variable regions of the integrons showed that this epidemic was caused by the clonal persistence and propagation of an MDR P. aeruginosa strain harboring the bla(IMP-1) gene and an aminoglycoside 6'-N-acetyltransferase gene, aac(6')-Iae in a class I integron (In113), whose integrase gene intl1 was disrupted by an IS26 insertion. Sequence analysis of the representative strain PA058447 resistance element containing the In113-derived gene cassette array showed that the element forms an IS26 transposon embedded in the chromosome. It has a Tn21 backbone and is composed of two segments sandwiched by three IS26s. In Japan, clonal nationwide expansion of an MDR P. aeruginosa NCGM2.S1 harboring chromosomally encoded In113 with intact intl1 is reported. Multilocus sequence typing and genomic comparison strongly suggest that PA058447 and NCGM2.S1 belong to the same clonal lineage. Moreover, the structures of the resistance element in the two strains are very similar, but the sites of insertion into the chromosome are different. Based on tagging information of the IS26 present in both resistance elements, we suggest that the MDR P. aeruginosa clone causing the epidemic in Hiroshima for the past 9 years originated from a common ancestor genome of PA058447 and NCGM2.S1 through an IS26 insertion into intl1 of In113 and through IS26-mediated genomic rearrangements.

Indexed as

Anti-Bacterial Agentsbeta-LactamasesDrug Resistance, Multiple, BacterialIntegronsJapanMicrobial Sensitivity TestsPseudomonas aeruginosaAnti-Bacterial Agentsbeta-Lactamases

Identifiers

PMID25712351
PMCPMC4394780
OpenAlexW2171379103

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.